Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acamprosate + Lumefantrine
|
DCKTNWN
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Alfacalcidol + Lumefantrine
|
DCZJYO1
|
Alfacalcidol
|
DD2 (Cell Line: DD2)
|
[2] |
Alfacalcidol + Lumefantrine
|
DCXDKND
|
Alfacalcidol
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Arfolitixorin + Lumefantrine
|
DC0TZN8
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemether + Lumefantrine
|
DCR20DL
|
Artemether
|
DD2 (Cell Line: DD2)
|
[2] |
Artemether + Lumefantrine
|
DC7EE3K
|
Artemether
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Atovaquone + Lumefantrine
|
DCEUC62
|
Atovaquone
|
DD2 (Cell Line: DD2)
|
[2] |
Atovaquone + Lumefantrine
|
DCBX116
|
Atovaquone
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Azelnidipine + Lumefantrine
|
DC0J6MV
|
Azelnidipine
|
DD2 (Cell Line: DD2)
|
[2] |
Azelnidipine + Lumefantrine
|
DC9ZVCH
|
Azelnidipine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Bafilomycin A1 + Lumefantrine
|
DC6UBW5
|
Bafilomycin A1
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Berberine + Lumefantrine
|
DCVOQR2
|
Berberine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
BHV-0223 + Lumefantrine
|
DCK6LV6
|
BHV-0223
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Biperiden + Lumefantrine
|
DC6RIBT
|
Biperiden
|
DD2 (Cell Line: DD2)
|
[2] |
Biperiden + Lumefantrine
|
DC5ZOTR
|
Biperiden
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Brincidofovir + Lumefantrine
|
DCF8QQH
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Bumetanide + Lumefantrine
|
DCY13FV
|
Bumetanide
|
DD2 (Cell Line: DD2)
|
[2] |
Bumetanide + Lumefantrine
|
DCPGWYB
|
Bumetanide
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Calmidazolium + Lumefantrine
|
DC3GE9I
|
Calmidazolium
|
DD2 (Cell Line: DD2)
|
[2] |
Carvedilol + Lumefantrine
|
DCAGZZI
|
Carvedilol
|
DD2 (Cell Line: DD2)
|
[2] |
Carvedilol + Lumefantrine
|
DC6CHFJ
|
Carvedilol
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Cerivastatin + Lumefantrine
|
DCRV44Q
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chlormezanone + Lumefantrine
|
DC9JGI4
|
Chlormezanone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chloroquine + Lumefantrine
|
DCEFL9D
|
Chloroquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Clindamycin + Lumefantrine
|
DCAQN5E
|
Clindamycin
|
DD2 (Cell Line: DD2)
|
[2] |
Clomiphene citrate + Lumefantrine
|
DCSCSQ8
|
Clomiphene citrate
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Dihydroergotamine + Lumefantrine
|
DCOXVP8
|
Dihydroergotamine
|
DD2 (Cell Line: DD2)
|
[2] |
Dihydroergotamine + Lumefantrine
|
DC5XFS7
|
Dihydroergotamine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Diltiazem + Lumefantrine
|
DCU56LI
|
Diltiazem
|
DD2 (Cell Line: DD2)
|
[2] |
Diltiazem + Lumefantrine
|
DCAMXE6
|
Diltiazem
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Disopyramide + Lumefantrine
|
DC4U3JS
|
Disopyramide
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Docetaxel + Lumefantrine
|
DCZB7S7
|
Docetaxel
|
DD2 (Cell Line: DD2)
|
[2] |
Docetaxel + Lumefantrine
|
DCIJEGD
|
Docetaxel
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Dofetilide + Lumefantrine
|
DC3RYX5
|
Dofetilide
|
DD2 (Cell Line: DD2)
|
[2] |
Doxepin + Lumefantrine
|
DCFIL85
|
Doxepin
|
DD2 (Cell Line: DD2)
|
[2] |
Eltanexor oral + Lumefantrine
|
DCBX9W2
|
Eltanexor oral
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Epinephrine + Lumefantrine
|
DCT81JT
|
Epinephrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Eszopiclone + Lumefantrine
|
DCDZ18S
|
Eszopiclone
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Fendiline + Lumefantrine
|
DC27FPP
|
Fendiline
|
DD2 (Cell Line: DD2)
|
[2] |
Fendiline + Lumefantrine
|
DCP3BN7
|
Fendiline
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Fenoprofen + Lumefantrine
|
DC0F5PW
|
Fenoprofen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
GDC-0032 + Lumefantrine
|
DCRF4WC
|
GDC-0032
|
DD2 (Cell Line: DD2)
|
[2] |
GDC-0032 + Lumefantrine
|
DCC7934
|
GDC-0032
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
GDC-0084 + Lumefantrine
|
DCS1X2H
|
GDC-0084
|
DD2 (Cell Line: DD2)
|
[2] |
Glipizide + Lumefantrine
|
DC806RA
|
Glipizide
|
DD2 (Cell Line: DD2)
|
[2] |
Glycyl-H 1152 + Lumefantrine
|
DC39ICS
|
Glycyl-H 1152
|
DD2 (Cell Line: DD2)
|
[2] |
Glycyl-H 1152 + Lumefantrine
|
DC2EIB5
|
Glycyl-H 1152
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Imatinib + Lumefantrine
|
DCLLOA8
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
IT-141 + Lumefantrine
|
DCE542S
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Ivermectin + Lumefantrine
|
DCSDCSE
|
Ivermectin
|
DD2 (Cell Line: DD2)
|
[2] |
JTC-801 + Lumefantrine
|
DCENM97
|
JTC-801
|
DD2 (Cell Line: DD2)
|
[2] |
KN-62 + Lumefantrine
|
DCRM15J
|
KN-62
|
DD2 (Cell Line: DD2)
|
[2] |
KN-62 + Lumefantrine
|
DCX2TA2
|
KN-62
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Lacidipine + Lumefantrine
|
DCJ4MER
|
Lacidipine
|
DD2 (Cell Line: DD2)
|
[2] |
Lacosamide + Lumefantrine
|
DCC0M2L
|
Lacosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lidoflazine + Lumefantrine
|
DCP0K0L
|
Lidoflazine
|
DD2 (Cell Line: DD2)
|
[2] |
Lidoflazine + Lumefantrine
|
DCH6XBJ
|
Lidoflazine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Lumefantrine + Otilonium bromide
|
DCWAXUA
|
Otilonium bromide
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Mebutamate
|
DCTZPJO
|
Mebutamate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Dantrolene
|
DC1IGYR
|
Dantrolene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + OZ277
|
DC4CUJA
|
OZ277
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + OZ277
|
DCNJ4ZV
|
OZ277
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Lumefantrine
|
DCA0UL9
|
Lumefantrine
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Lumefantrine
|
DCMLYH4
|
Lumefantrine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Trametinib
|
DCM7HDN
|
Trametinib
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Dactinomycin
|
DCAC0YP
|
Dactinomycin
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Dactinomycin
|
DCQM3W0
|
Dactinomycin
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Tindamax
|
DCUK46J
|
Tindamax
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Carfilzomib
|
DC878IQ
|
Carfilzomib
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Artemether
|
DCFJJBJ
|
Artemether
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Artemether
|
DC4D1NQ
|
Artemether
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Panobinostat
|
DC3XH7U
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Lumefantrine + Sivelestat
|
DC7CHDT
|
Sivelestat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Alvespimycin hydrochloride
|
DC7M0ER
|
Alvespimycin hydrochloride
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + MK-3207
|
DCHVEA8
|
MK-3207
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + MK-3207
|
DCBGPIR
|
MK-3207
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Pepstatin
|
DCO1L3O
|
Pepstatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Azelnidipine
|
DCARNW7
|
Azelnidipine
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Azelnidipine
|
DCA0BA3
|
Azelnidipine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Diltiazem
|
DCHY6UK
|
Diltiazem
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Buspirone
|
DC5SPHZ
|
Buspirone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Terameprocol
|
DCCSH5V
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Emetine
|
DCWIPUD
|
Emetine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Chlorzoxazone
|
DCLU6IU
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Docetaxel
|
DCQP6RV
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Marizomib
|
DCOJ2AM
|
Marizomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Lumefantrine + Cycloheximide
|
DCBM8EZ
|
Cycloheximide
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Sitagliptin
|
DCU0U7Y
|
Sitagliptin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + BIO-300
|
DCLXXYB
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Eflornithine
|
DCYLHB3
|
Eflornithine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Tiagabine
|
DC54RTZ
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Diazoxide
|
DC21WL8
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + KN-62
|
DCYGMT0
|
KN-62
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Idarubicin
|
DCBHVI6
|
Idarubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Epothilone B
|
DCKCPWF
|
Epothilone B
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Probenecid
|
DCGWKKM
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Bortezomib
|
DCH6ONM
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Methylene blue
|
DCKT6R1
|
Methylene blue
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Methylene blue
|
DC7ONP8
|
Methylene blue
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Moricizine
|
DCY7K04
|
Moricizine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Artemisinin
|
DC3UBZB
|
Artemisinin
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Artemisinin
|
DC22SS8
|
Artemisinin
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Dopamine
|
DCV6QHL
|
Dopamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Miconazole
|
DCKICWE
|
Miconazole
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Trimethobenzamide
|
DCJHYIO
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Omacetaxine mepesuccinate
|
DCXKKNB
|
Omacetaxine mepesuccinate
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Omacetaxine mepesuccinate
|
DCBE6W0
|
Omacetaxine mepesuccinate
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Maprotiline
|
DCVJ5AU
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Leflunomide
|
DCM7AO5
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Naltrexone
|
DC96TOL
|
Naltrexone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + GDC-0032
|
DC8DKRV
|
GDC-0032
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Piperaquine
|
DCZP7LM
|
Piperaquine
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Piperaquine
|
DCZ8HQQ
|
Piperaquine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + MK-4815
|
DCAD8AM
|
MK-4815
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + MK-4815
|
DCTVGE2
|
MK-4815
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + NVP-AUY922
|
DCQ8O8T
|
NVP-AUY922
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + NVP-AUY922
|
DCAMDLG
|
NVP-AUY922
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Mycophenolic acid
|
DC7IFWR
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Oxandrolone
|
DCSW6GD
|
Oxandrolone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Cyclosporin A
|
DCBSRNF
|
Cyclosporin A
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Cyclosporin A
|
DC9U1KA
|
Cyclosporin A
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Lumefantrine + Doxorubicin
|
DCN673Y
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Zileuton
|
DCRBN1A
|
Zileuton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Vorinostat
|
DC57VFR
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lumefantrine + Atovaquone
|
DC49E4K
|
Atovaquone
|
DD2 (Cell Line: DD2)
|
[2] |
Lumefantrine + Atovaquone
|
DC53RUQ
|
Atovaquone
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
MANOALIDE + Lumefantrine
|
DC949M1
|
MANOALIDE
|
DD2 (Cell Line: DD2)
|
[2] |
MANOALIDE + Lumefantrine
|
DC9BSMY
|
MANOALIDE
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Mefloquine + Lumefantrine
|
DC3O5Q3
|
Mefloquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Mefloquine + Lumefantrine
|
DCDRBXT
|
Mefloquine
|
DD2 (Cell Line: DD2)
|
[2] |
Mefloquine + Lumefantrine
|
DCANIUA
|
Mefloquine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Methotrexate + Lumefantrine
|
DC62WWB
|
Methotrexate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Methylene blue + Lumefantrine
|
DCWA7VW
|
Methylene blue
|
DD2 (Cell Line: DD2)
|
[2] |
Methylene blue + Lumefantrine
|
DCCWZC8
|
Methylene blue
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Miconazole + Lumefantrine
|
DCFSGF8
|
Miconazole
|
DD2 (Cell Line: DD2)
|
[2] |
Miconazole + Lumefantrine
|
DC2PJQG
|
Miconazole
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Midostaurin + Lumefantrine
|
DCQWNLF
|
Midostaurin
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
MK-3207 + Lumefantrine
|
DCPSRUR
|
MK-3207
|
DD2 (Cell Line: DD2)
|
[2] |
MK-3207 + Lumefantrine
|
DCLO2A1
|
MK-3207
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
MK-4815 + Lumefantrine
|
DC8FAPZ
|
MK-4815
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Nabilone + Lumefantrine
|
DCCXQBJ
|
Nabilone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Naftopidil + Lumefantrine
|
DCCWHXS
|
Naftopidil
|
DD2 (Cell Line: DD2)
|
[2] |
Naltrexone + Lumefantrine
|
DC7YSN9
|
Naltrexone
|
DD2 (Cell Line: DD2)
|
[2] |
Naltrexone + Lumefantrine
|
DCZOHOX
|
Naltrexone
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Nitisinone + Lumefantrine
|
DC2QKUX
|
Nitisinone
|
DD2 (Cell Line: DD2)
|
[2] |
Omacetaxine mepesuccinate + Lumefantrine
|
DCROSTP
|
Omacetaxine mepesuccinate
|
DD2 (Cell Line: DD2)
|
[2] |
Omacetaxine mepesuccinate + Lumefantrine
|
DCG4U36
|
Omacetaxine mepesuccinate
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Otilonium bromide + Lumefantrine
|
DCLR0MA
|
Otilonium bromide
|
DD2 (Cell Line: DD2)
|
[2] |
Otilonium bromide + Lumefantrine
|
DCWJEI6
|
Otilonium bromide
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Panobinostat + Lumefantrine
|
DCCD1U6
|
Panobinostat
|
DD2 (Cell Line: DD2)
|
[2] |
Panobinostat + Lumefantrine
|
DCUSXDU
|
Panobinostat
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Pentamidine + Lumefantrine
|
DCKF4U3
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Piperaquine + Lumefantrine
|
DCYC30O
|
Piperaquine
|
DD2 (Cell Line: DD2)
|
[2] |
Piperaquine + Lumefantrine
|
DC1EN2X
|
Piperaquine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
PMID28460551-Compound-2 + Lumefantrine
|
DCC628K
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Pomalidomide + Lumefantrine
|
DCVL0MT
|
Pomalidomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Proguanil + Lumefantrine
|
DCJTE22
|
Proguanil
|
DD2 (Cell Line: DD2)
|
[2] |
Proguanil + Lumefantrine
|
DC27E4Y
|
Proguanil
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Pyrimethamine + Lumefantrine
|
DCFU6NO
|
Pyrimethamine
|
DD2 (Cell Line: DD2)
|
[2] |
Pyrimethamine + Lumefantrine
|
DC66YG2
|
Pyrimethamine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Pyronaridine + Lumefantrine
|
DC56219
|
Pyronaridine
|
DD2 (Cell Line: DD2)
|
[2] |
Quinine + Lumefantrine
|
DC26EUD
|
Quinine
|
DD2 (Cell Line: DD2)
|
[2] |
Quinine + Lumefantrine
|
DCQOVQW
|
Quinine
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Ribavirin-TP + Lumefantrine
|
DCTC0DK
|
Ribavirin-TP
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Ritonavir + Lumefantrine
|
DC12V1J
|
Ritonavir
|
DD2 (Cell Line: DD2)
|
[2] |
Ritonavir + Lumefantrine
|
DCA8G3Z
|
Ritonavir
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Safinamide mesylate + Lumefantrine
|
DCYZMPC
|
Safinamide mesylate
|
DD2 (Cell Line: DD2)
|
[2] |
Sarpogrelate + Lumefantrine
|
DCMPY33
|
Sarpogrelate
|
DD2 (Cell Line: DD2)
|
[2] |
Sarpogrelate + Lumefantrine
|
DCWQ7O7
|
Sarpogrelate
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
SB 228357 + Lumefantrine
|
DC774SR
|
SB 228357
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Sorafenib + Lumefantrine
|
DC3I0MT
|
Sorafenib
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
Sotalol + Lumefantrine
|
DCIHU9C
|
Sotalol
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Sulfapyridine + Lumefantrine
|
DCLS42K
|
Sulfapyridine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Sumatriptan + Lumefantrine
|
DCXG4E9
|
Sumatriptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Thiolactomycin + Lumefantrine
|
DC3RA4Y
|
Thiolactomycin
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Topiramate + Lumefantrine
|
DCNJZE3
|
Topiramate
|
DD2 (Cell Line: DD2)
|
[2] |
Triflupromazine + Lumefantrine
|
DCA6CJM
|
Triflupromazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Trihexyphenidyl + Lumefantrine
|
DCOM53W
|
Trihexyphenidyl
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Ursodeoxycholic acid + Lumefantrine
|
DCEULKA
|
Ursodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Verapamil + Lumefantrine
|
DC8O7LO
|
Verapamil
|
DD2 (Cell Line: DD2)
|
[3] |
Vorinostat + Lumefantrine
|
DC2WJRV
|
Vorinostat
|
DD2 (Cell Line: DD2)
|
[2] |
Vorinostat + Lumefantrine
|
DCISVDB
|
Vorinostat
|
Hepatoblastoma (Cell Line: HB3)
|
[2] |
VR-776 + Lumefantrine
|
DC2E2JK
|
VR-776
|
DD2 (Cell Line: DD2)
|
[2] |
WAY-100635 + Lumefantrine
|
DCHBDFV
|
WAY-100635
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
ZM-447439 + Lumefantrine
|
DCPAWN0
|
ZM-447439
|
DD2 (Cell Line: DD2)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|